| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| North Run Strategic Opportunities Fund I, LP | 10%+ Owner | 867 BOYLSTON STREET, 5TH FLOOR #1361, BOSTON | /s/ North Run Strategic Opportunities Fund I, LP, By: Thomas B. Ellis, Member of GP | 09 Jan 2026 | 0002052913 |
| North Run Strategic Opportunities Fund I GP, LLC | 10%+ Owner | 867 BOYLSTON STREET, 5TH FLOOR #1361, BOSTON | /s/ North Run Strategic Opportunities Fund I GP, LLC, By: Thomas B. Ellis, Member | 09 Jan 2026 | 0002058804 |
| NR-SOF I (Co-Invest I), LP | 10%+ Owner | 867 BOYLSTON STREET, 5TH FLOOR #1361, BOSTON | /s/ NR-SOF I (Co-Invest I), LP, By: Thomas B. Ellis, Member of GP | 09 Jan 2026 | 0002097542 |
| ELLIS THOMAS B | Director, 10%+ Owner | 867 BOYLSTON STREET, 5TH FLOOR #1361, BOSTON | /s/ Thomas B. Ellis | 09 Jan 2026 | 0001283774 |
| HAMMER TODD B | 10%+ Owner | 867 BOYLSTON STREET, 5TH FLOOR #1361, BOSTON | /s/ Todd B. Hammer | 09 Jan 2026 | 0001283775 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | CREX | Series A Convertible Preferred Stock | 06 Nov 2025 | Common Stock | 10,000,001 | $3.00 | See footnotes | F1, F2, F3 |
| Id | Content |
|---|---|
| F1 | The reported securities consist of 25,000 shares of Series A Convertible Preferred Stock ("Preferred Stock" directly held by North Run Strategic Opportunities Fund I, LP ("NR-SOF") and 5,000 shares of Preferred Stock NR-SOF I (Co-Invest I), LP ("NR Co-Invest"), and may be deemed to be indirectly beneficially owned by North Run Strategic Opportunities Fund I GP, LLC ("NR GP") as the general partner of NR-SOF and NR Co-Invest. The reported securities may also be deemed to be indirectly beneficially owned by Thomas B. Ellis and Todd B. Hammer as members of NR GP. Each share of preferred stock has a stated value of $1,000 and a conversion price at issuance of $3.00. |
| F2 | The Series A Convertible Preferred Stock has no expiration date and is convertible at any time at the option of the holder, subject to blocker provisions that prevents conversion into shares of Common Stock of the Issuer if the reporting person, together with its affiliates, would beneficially own more than 19.99% of the Common Stock following such conversion and that prevent conversion to the extent that all shares of Common Stock issued upon conversion of shares of Series A Convertible Preferred Stock would exceed 2,102,734. |
| F3 | North Run Strategic Opportunities Fund I GP, LLC, North Run GP, LP, North Run Advisors, LLC, Thomas B. Ellis, Todd B. Hammer and Michael Bosco disclaim beneficial ownership of the reported securities except to the extent of their respective pecuniary interest therein, and this report shall not be deemed an admission that any of them are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. |
Each of NR-SOF, NR Co-Invest, and NR GP may be deemed to be a director by deputization for purposes of Section 16 under the Securities and Exchange Act of 1934, as amended, by virtue of the fact that Thomas B. Ellis, a member of NR GP, currently serves on the board of directors of the Issuer. Exhibit List: Exhibit 24.1 – Power of Attorney for Thomas B. Ellis